Vitamin D Deficiency Effects: Sunlight, D3 vs D2, and Optimal Levels

A Deficiency Hidden in Plain Sunlight

Approximately 40% of American adults have serum 25-hydroxyvitamin D [25(OH)D] levels below 20 ng/mL, the threshold the National Academy of Medicine defines as deficient for bone health, according to data from NHANES 2011–2014. Among Black Americans, that figure reaches 82%, driven by melanin's role in filtering the UV radiation that triggers vitamin D synthesis. The paradox is that vitamin D deficiency is largely preventable through sunlight exposure — yet modern indoor lifestyles, sunscreen use, high-latitude residence, and air pollution have collectively severed the link between humans and the one resource evolution assumed would always be abundant.

How Sunlight Makes Vitamin D

UVB radiation (wavelengths 290–315 nm) converts 7-dehydrocholesterol in skin cells to previtamin D3, which thermally isomerizes to vitamin D3 (cholecalciferol) within hours. The liver then hydroxylates D3 to 25(OH)D, and the kidney performs the final hydroxylation to 1,25-dihydroxyvitamin D (calcitriol), the biologically active hormone. Multiple factors throttle this synthesis:

• Latitude: Above 37° north (roughly San Francisco / Richmond, Virginia), UVB angle from November through March is insufficient to drive meaningful synthesis regardless of time outdoors.
• Skin pigmentation: Fitzpatrick type VI skin requires 3–6 times longer UVB exposure than type I to produce equivalent vitamin D3.
• SPF 15 sunscreen: Reduces cutaneous vitamin D synthesis by approximately 99% when applied correctly — though real-world application is typically insufficient for that effect.
• Time of day: UVB is only present when the solar zenith angle is below 60°, roughly 10 a.m. to 3 p.m. in summer at mid-latitudes.
• Age: Skin of adults over 70 produces 25–50% less vitamin D3 per unit UVB than young adult skin.

D2 vs. D3: The Bioavailability Debate

Vitamin D2 (ergocalciferol) is derived from UV-irradiated fungi and used in many prescription-dose preparations. Vitamin D3 (cholecalciferol) is the form produced by human skin and found in animal-sourced foods. A meta-analysis by Tripkovic et al. (2012, American Journal of Clinical Nutrition) analyzing 10 randomized trials found that D3 was approximately 87% more effective at raising serum 25(OH)D than D2 when taken as a daily supplement. The mechanistic explanation involves D3's longer half-life in circulation and superior binding to vitamin D-binding protein (DBP).

The Optimal Level Controversy

The "optimal" 25(OH)D level is genuinely contested. The National Academy of Medicine (2011) set the sufficiency threshold at 20 ng/mL for bone health, calculating that this level is adequate for 97.5% of the population. The Endocrine Society, in its clinical practice guideline, targets 30 ng/mL as minimum sufficiency. A separate cohort of researchers, associated with the Grassroots Health Nutrient Research Institute, advocates 40–60 ng/mL based on associations with reduced cancer incidence, autoimmune disease, and all-cause mortality in observational data.

The observational associations are striking. The VITAL trial (2019, NEJM), a large randomized controlled trial of 2,000 IU/day D3 in 25,871 adults, found no significant reduction in primary cardiovascular events or invasive cancer incidence overall — though post-hoc analysis showed a 17% reduction in cancer mortality and a 22% reduction in incident cancer in those who had taken the supplement for more than 2 years. The gap between observational promise and RCT results likely reflects reverse causation in observational studies (illness lowers vitamin D) and the difficulty of supplementing into adequacy in an already-sufficient population.

Health Effects of Deficiency

Established consequences of vitamin D deficiency include:

• Rickets in children — failure of bone mineralization causing skeletal deformity, still prevalent in equatorial Africa and South Asia despite abundant sunlight (due to dietary calcium deficiency compounding the problem).
• Osteomalacia in adults — bone pain, muscle weakness, and stress fractures from inadequate bone mineralization.
• Secondary hyperparathyroidism — low calcium absorption triggers PTH secretion, accelerating bone resorption.
• Muscle weakness — vitamin D receptors are expressed in skeletal muscle; deficiency correlates with fall risk in older adults (meta-analysis: Bischoff-Ferrari, 2009).

Toxicity Threshold

Vitamin D toxicity (hypervitaminosis D) causes hypercalcemia, producing nausea, polyuria, confusion, and renal damage. The National Academy of Medicine set the tolerable upper intake level at 4,000 IU/day for adults. Documented toxicity cases typically involve 25(OH)D levels above 150 ng/mL, generally requiring sustained intake above 10,000 IU/day. A 2019 case series in NEJM described a man who developed hypercalcemia after taking 8,000–12,000 IU/day for two years, though he had a concurrent granulomatous condition that accelerated calcitriol production. Sunlight exposure alone cannot cause toxicity — the skin degrades excess previtamin D3 on prolonged exposure.

This article is for informational purposes only. Consult a qualified healthcare professional.